[2-Oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonic Acid Dimethyl Ester

We are [2-Oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonic Acid Dimethyl Ester CAS:54094-19-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: [2-Oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonic Acid Dimethyl Ester
CAS.NO:54094-19-8
Synonyms:
Dimethyl [2-Oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate
1-dimethoxyphosphoryl-3-[3-(trifluoromethyl)phenoxy]propan-2-one

Molecular Formula: C12H14F3O5P
Molecular Weight: 326.20600

Physical and Chemical Properties:
Density: 1.32g/cm3
Boiling point: 378.6ºC at 760mmHg
Melting point:/
Flash point:182.8ºC
Refractive index:1.454

Specification:
Appearance: White  powder
Purity:≥99%
Moisture Content: 0.25%
Impurity: 0.30%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Travoprost CAS:157283-68-6

[2-Oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonic Acid Dimethyl Ester


Related News: The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.Ethyl (2R,4R)-4-methyl-2-piperidinecarboxylate CAS:74892-82-3 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.(2S)-Amino(3-hydroxyadamantan-1-yl)acetic acid CAS:709031-29-8 In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.1-(3-Amino-2-hydroxyphenyl)ethanone In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.

Related Products
Product Name
2-methylfuran-3-thiol View Details
4-Chloro-3-nitrobenzotrifluoride View Details
Diethyl disulfide View Details
2-Bromo-3-chloro-5-methylpyridine manufacturer 4-Nitro-3-trifluoromethyl aniline manufacturer Dibenzo[b,d]thiophene-4,6-diboronic acid manufacturer 3-Chloro-2-iodopyridine manufacturer 2,4,5-Triamino-6-hydroxypyrimidine sulfate manufacturer